Bret Jensen, Biotech Gems

These Four Biotech Stocks Have Potential Upcoming Catalysts

May 1, 2017

We could see key trial results or FDA approvals in the months ahead...
Read More »

Four Stocks for Value and Growth in an Overvalued Market

April 21, 2017

Two of these companies are well-managed, have solid balance sheets, are reasonably valued and pay over 6% dividend payouts...
Read More »

These 3 Growth Stocks Could Do Well for the Rest of 2017

April 16, 2017

One is up some 60% since I first positively profiled it in December, living up so far to its "Home Run" potential…
Read More »

Warning: Avoid This Stock at All Costs

March 27, 2017

Investing in it is dangerous...
Read More »

3 Small Biotech Moonshots to Add to Your Portfolio

March 20, 2017

With the entire sector gaining steam, there's still plenty of upside left...
Read More »

I’ve Recently Bought More Shares of These Stocks

March 17, 2017

Not only are the companies well-managed, reasonably valued, and paying substantial dividends, but they've also seen insider buying in their shares recently...
Read More »

3 Promising Biotech Rocket Stocks to Add to Your Portfolio

March 3, 2017

All three have had very positive news come out recently and have seen their stock prices start to rise. With the sector starting to wake back up, these stocks can run much, much higher...
Read More »

These Types of Stocks Are Becoming Bargains

February 27, 2017
bargain tag

They're overlooked investment opportunities in humanity's most important resource...
Read More »

Two Cash-Cow Tech Stocks to Buy Over the Snap IPO

February 20, 2017

In short, these stocks offer investors a much better value...
Read More »

3 Attractive Growth Stocks with Near-Term Catalysts

February 14, 2017

I've recently added to my position in each of these names...
Read More »